The global mesenchymal stem cells market size to reach USD 2,518.5 Million by 2026, growing at a CAGR of 7.0% during forecast period, according to a new research report published by Polaris Market Research. The report ‘Mesenchymal Stem Cells Market, [By Source (Bone Marrow, Umbilical Cord Blood, Peripheral Blood, Lung Tissue, Synovial Tissues, Amniotic Fluids, Adipose Tissues); By Application (Injuries, Drug Discovery, Cardiovascular Infraction, Others); By Region]: Market Size & Forecast, 2018 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends. The market was valued at USD 1,335.1 million in 2017. In 2017, the drug discovery application dominated the market, in terms of revenue. North America region is observed to be the leading contributor in the global market revenue in 2017.
are adult stem cells, which are traditionally found in the bone
marrow. However, they can also be parted from other available tissues including
peripheral blood, cord blood, fallopian tube. These stem cells mainly function
for the replacement of damaged cell and tissues. The potential of these cell is
to heal the damaged tissue with no pain to the individual. Scientists are
majorly focusing on developing new and innovative treatment options for the
various chronic diseases like cancer. Additionally, the local governments have
also taken various steps for promoting the use of these stem cells.
Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/mesenchymal-stem-cells-market/request-for-sample
The major key players operating in the industry are Cell
Applications, Inc., Cyagen Biosciences Inc. Axol Bioscience Ltd., Cytori
Therapeutics Inc., Stem cell technologies Inc., Celprogen, Inc.
BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc. These
companies launch new products and undertake strategic collaboration and
partnerships with other companies in this market to expand presence and to meet
the increasing needs and requirements of consumers.
The significant aspects that are increasing the development in
market for mesenchymal stem cells consist of enhancing need for these stem
cells as an efficient therapy option for knee replacement. Raising senior
populace throughout the world, as well as increasing frequency of numerous
persistent conditions consisting of cancer cells, autoimmune illness, bone and
cartilage diseases are elements anticipated to enhance the market development
throughout the forecast period. The mesenchymal stem cells market is
obtaining favorable assistance by the reliable federal government policies, as
well as funding for R&D activities which is anticipated to influence the
market growth over coming years. According to the reports released by world
health organization (WHO), by 2050 individuals aged over 60 will certainly make
up greater than 20% of the globe’s population. Of that 20%, a traditional quote
of 15% is estimated to have symptomatic OA, as well as one-third of these
individuals are expected to be influenced by extreme specials needs. Taking
into consideration all these aspects, the market for mesenchymal stem cells
will certainly witness a substantial development in the future.
Get Special Discount Offer At @ https://www.polarismarketresearch.com/industry-analysis/mesenchymal-stem-cells-market/request-for-discount-pricing
Increasing demand for better healthcare facilities, rising
geriatric population across the globe, and continuous research and development
activities in this area by the key players is expected to have a positive
impact on the growth of Mesenchymal Stem Cells market. North America generated
the highest revenue in 2017, and is expected to be the leading region globally
during the forecast period. The Asia Pacific market is also expected to
witness significant market growth in coming years. Developing healthcare
infrastructure among countries such as China, India in this region is observed
to be the major factor promoting the growth of this market during the forecast
period.
